Hongmei Zeng
Biographic Data
| ID | 4973693 |
|---|---|
| NAME | Hongmei Zeng |
| GIVEN NAMES | Hongmei |
| FAMILY NAME | Zeng |
| SIGNATURE | ZENG H |
| AFFILIATIONS | Chinese Academy of Medical Sciences & Peking Union Medical College |
| ORCID | 0000-0003-3999-3081 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Cancer incidence and mortality in China, 2022
Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countries around the world every two years. To ensure consistency between the actual surveillance data in China and the data published by IARC, NCC has received approval from the National Health Commission a…
Additional outpatient expenditures due to heatwaves
As global temperatures rise, the impact on health becomes increasingly apparent, especially for vulnerable seniors. This study analyzed the additional financial burden caused by heatwaves on outpatient healthcare spending among China’s older people, using data from the China Health and Retirement Longitudinal Study (CHARLS) covering 126 cities between 2011 and 2018. Applying generalized estimating equations (GEE) models and incorporating local we…
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA
Background Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. Methods We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate asso…
Provincial-level cancer burden attributable to active and second-hand smoking in China
Comprehensive smoke-free policies in China should expand to all provinces, notably those with a higher burden of cancer attributable to smoking, instead of being mostly limited to Beijing and some other metropolitan areas
Cancer statistics in China, 2015
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the Natio…
No prominent works on this page.
Cancer statistics in China, 2015
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the Natio…
Provincial-level cancer burden attributable to active and second-hand smoking in China
Comprehensive smoke-free policies in China should expand to all provinces, notably those with a higher burden of cancer attributable to smoking, instead of being mostly limited to Beijing and some other metropolitan areas
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA
Background Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. Methods We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate asso…
Cancer incidence and mortality in China, 2022
Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countries around the world every two years. To ensure consistency between the actual surveillance data in China and the data published by IARC, NCC has received approval from the National Health Commission a…
Additional outpatient expenditures due to heatwaves
As global temperatures rise, the impact on health becomes increasingly apparent, especially for vulnerable seniors. This study analyzed the additional financial burden caused by heatwaves on outpatient healthcare spending among China’s older people, using data from the China Health and Retirement Longitudinal Study (CHARLS) covering 126 cities between 2011 and 2018. Applying generalized estimating equations (GEE) models and incorporating local we…
Medicine (5 works) · Global Cancer Incidence and Screening (4 works) · Cancer (3 works) · Demography (3 works) · Cancer registry (2 works) · China (2 works) · Environmental health (2 works) · Incidence (geometry) (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works)